RadNet Posts Higher Revenue and Operating Income on the Quarter and the Year-to-Date, While Parent Net Income Softens and the Half-Year Result Stays in Loss

Bottom line

- For the three-month reporting period, RadNet, Inc. 1 per diluted share USD/SHARES and Net Income (Loss) Attributable to Parent was $7,530,000 USD, all referencing the three months ended June 30, 2026. 33 per diluted share USD/SHARES, each tied to the six months ended June 30, 2026.

- The filing is the 10-Q for period-ended-2026-06-30, filed under accession 0001628280-26-055338 by the entity identified by CIK 0000790526, with the financial line items drawn from the consolidated statements presented in Item 1. - Management describes RadNet, Inc. as a national provider of freestanding, fixed-site outpatient diagnostic imaging services operating across multiple states, with a multi-modality strategy spanning MRI, CT, PET, nuclear medicine, mammography, ultrasound, X-ray, fluoroscopy and related procedures, and additional Artificial Intelligence subsidiaries.

- Management states that operations comprise two reportable segments — Imaging Centers and Digital Health — for this reporting period, with further detail available in Note 5, Segment Reporting, and that the consolidated group includes certain variable interest entities that the registrant consolidates as primary beneficiary. - Management notes that the consolidated financial statements capture non-cash investing and financing items, including equipment and leasehold improvements acquired but not yet paid, as referenced in the supplemental schedule and further described within Note 6.

19 per diluted share USD/SHARES, with each line remaining profitable year over year. 32 per diluted share USD/SHARES, with each line remaining in loss year over year. - The year-to-date operating profit improvement coexists with a year-to-date bottom-line loss that is wider than the prior-year comparative loss, which is consistent with the directional contrast already summarized for that window.

- The quarter-level bottom-line decrease against a higher revenue and higher operating-income base likewise reflects the directional contrast already summarized for that window. - No counter-evidence has been identified within the source scope beyond the directional contrasts already summarized above. The filing evidence does not attribute this change to any single cause.

UNKNOWN: - The filing evidence contains no peer or industry comparison. The filing evidence contains no peer or industry comparison. - The filing evidence does not attribute the reported year-over-year changes to any single cause.

Financial performance

- For the three months ended June 30, 2026, the company stayed profitable on the top line, with $622,720,000 running higher than the prior-year $498,230,000; $39,468,000 also exceeded the prior-year $30,879,000, and net income attributable to parent reached $7,530,000 versus $14,454,000 a year earlier. 19 per diluted share USD/SHARES, both positive. Each of these comparisons is authorized only as a directional movement; no transition or cause is authorized.

- For the six months ended June 30, 2026, the picture inverted on the bottom line. Revenue of $1,198,351,000 was higher than the prior-year $969,629,000, and operating income of $15,565,000 was higher than $6,778,000, keeping the operating line in a profit-to-profit transition. 32 per diluted share USD/SHARES, both losses.

The filing evidence does not attribute this change to any single cause. - The interim statements were prepared in line with the instructions to 10-Q and the referenced Regulation S-X rule, omitting certain footnote detail required in a full set of GAAP statements; management states that normal recurring adjustments are, in their opinion, sufficient for a fair presentation. The results of any interim period are flagged as not necessarily indicative of full-year results, so the three-month and six-month windows should be read alongside the most recent annual report on the referenced Form.

- The reported operating footprint comprises two segments, Imaging Centers and Digital Health, with segment detail carried in Note 5; the balance sheet itself sits in Item 1. The accounting landscape also includes variable interest entities consolidated because RadNet is the primary beneficiary. The in-scope consolidated professional medical groups operate in Arizona, California, Delaware, Maryland, Florida and New York, and their de minimis equity and insignificant operating assets mean substantially all post-expense cash flows transfer to RadNet.

The related management-fee billed service revenue for the quarter and the year-to-date are reported only in narrative form here, with the exact amounts unavailable in the catalog and so not directly cited. - Capital-structure items, including credit facilities, notes payable, and finance leases, sit behind Note 6, while Note 7 governs stock-based compensation and the accounts-receivable accounting posture. Readers building a baseline can cross-reference those notes for non-GAAP context that is not separately tabulated in this section.

- For a parallel read on a peer that also reported higher revenue, higher operating income, higher net income, and higher diluted EPS across a twelve-month window with each line remaining profitable year over year, see Covista Inc. Reports Higher Revenue, Operating Income, Net Income, and Diluted EPS Across the Twelve-Month Period Versus the Prior-Year Comparative, With Each Line Remaining Profitable Year Over Year. The filing evidence contains no peer or industry comparison.

- QOQ baselines (sequential quarter comparisons) and forward management guidance are not provided in the filing evidence for this section, so no qualitative directional claim is offered on those dimensions.

Operating drivers and segments

- The reporting framework separates operations into two reportable segments for financial reporting — Imaging Centers and Digital Health — with consolidated revenue also reflecting variable interest entities tied to the professional medical practice. The Imaging Centers segment remains the dominant contributor to consolidated results, given its scale as a national provider of freestanding, fixed-site outpatient diagnostic imaging services across multiple states. The Digital Health segment, through subsidiaries developing Artificial Intelligence products and solutions intended to enhance interpretation of radiographic images, is a smaller, growth-oriented pillar. The consolidated group also includes professional corporations that RadNet consolidates as the primary beneficiary under the variable interest entity analysis disclosed in the basis of presentation. - On a top-line basis, Revenue from Contract with Customer, Excluding Assessed Tax was higher than the prior-year comparative on the three-month reporting period and higher than the prior-year comparative on the six-month year-to-date period, leaving both reported windows directionally positive versus their prior periods. On the operating line, Operating Income (Loss) was higher than the prior-year comparative on the three-month reporting period and higher than the prior-year comparative on the six-month year-to-date period, with both windows remaining in profit versus the prior periods. The authorized relations thus support a top-line expansion accompanied by an operating-line expansion across both the quarter and the year-to-date window, with the operating line preserved as profitable in each comparison. - No segment-level revenue, segment-level operating income, or segment-level margin disclosure is provided within the filing evidence available to this section, so the contribution split between Imaging Centers and Digital Health cannot be independently reconstructed from what is cited here.

- Management frames the consolidated group as a national provider of freestanding, fixed-site outpatient diagnostic imaging services, operating directly or through joint ventures with hospitals and health-system partners. The services portfolio spans MRI, CT, PET, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and related procedures, which management presents as a multi-modality strategy intended to diversify revenue streams, reduce exposure to reimbursement changes, and offer patients and referring physicians a single location capable of meeting multiple procedural needs. - Management also describes certain subsidiaries that develop Artificial Intelligence products and solutions designed to enhance interpretation of radiographic images, which is consistent with the Digital Health segment disclosed for financial reporting purposes. Together with the Imaging Centers segment, management presents this structure as a means of diversifying earnings drivers and supporting growth. - For further financial information about these segments, the filing refers readers to Note 5, Segment Reporting, while Item 1 is the location of the condensed consolidated balance sheet and Note 6 and Note 7 address credit facilities and stock-based compensation, respectively.

<prose> - The consolidated operating performance for RadNet, Inc. in the period covered by 10-Q for period-ended-2026-06-30, filed under 0001628280-26-055338 with CIK 0000790526 and identified by ticker RDNT, combines a sizable, geographically diversified imaging-center footprint with an emerging Digital Health line. Across the three-month reporting period, Revenue from Contract with Customer, Excluding Assessed Tax was higher than the prior-year comparative, and Operating Income (Loss) was higher than the prior-year comparative, with both lines remaining profitable relative to the prior period. The same pattern holds across the six-month year-to-date period, where Revenue from Contract with Customer, Excluding Assessed Tax was higher than the prior-year comparative and Operating Income (Loss) was higher than the prior-year comparative, again leaving both lines in profit versus the prior period. - Independent analysis from this section is limited to what the filing evidence supports. The segment narrative identifies Imaging Centers and Digital Health as the two reportable segments and consolidates variable interest entities tied to the professional medical practice, but no segment-level revenue, operating income, or margin figures are reproduced within the cited evidence. The operating-line expansion therefore cannot be decomposed between the two segments on the basis of what is available here, and the catalog supplies no peer or industry comparison to benchmark either segment. The filing evidence contains no peer or industry comparison. - On causality, the filing evidence does not attribute the top-line or operating-line changes to any single cause. The filing evidence does not attribute this change to any single cause. Management describes a multi-modality strategy intended to diversify revenue streams and reduce exposure to reimbursement changes, and references Digital Health subsidiaries developing Artificial Intelligence products and solutions intended to enhance interpretation of radiographic images, but these are framed as structural rather than as quantified drivers of the period's results. Readers interested in how an operating-line expansion can translate into reported earnings can review Covista Inc. Reports Higher Revenue, Operating Income, Net Income, and Diluted EPS Across the Twelve-Month Period Versus the Prior-Year Comparative, With Each Line Remaining Profitable Year Over Year for a comparable profit-preserving year-over-year pattern.

Cash flow and capital

Across the year-to-date window, operating cash flow is positive for the current six-month period and is authorized as higher than the prior-year comparative six-month period. Both the current and prior-year financing lines are positive, with the current financing line authorized as higher than the prior year. Investing activities are negative in both windows, with the current investing outflow authorized as lower than the prior-year comparative outflow. No cause is authorized for any of these cash-flow moves, so the change in each line is reported without driver language: The filing evidence does not attribute this change to any single cause..

The balance sheet at the period-end date shows Cash and Cash Equivalents, at Carrying Value, Long-term Debt Excluding Current Maturities, Accounts Receivable after Allowance for Credit Loss (Current), and Accounts Payable and Accrued Liabilities (Current). These five positions are taken straight from the condensed consolidated balance sheet referenced in the cited note, without any sub-totalling or ratio work in this section. Because the catalog carries no totals or composition keys beyond those line items, broader liquidity, leverage, or working-capital ratios are not derived here; the only balance-sheet comparisons the catalog supports are the line-level figures themselves. Segment or business-unit level balance-sheet detail is not separately disclosed for these dimensions: The filing evidence does not disclose segment-level detail for this dimension..

On capital allocation, the filing itself links the long-term debt balance to the credit-facilities and finance-lease discussion in the cited note, and the accounts-receivable line to the credit-loss allowance discussion in a separate cited note, but the filing evidence does not state a single capital-allocation objective, dividend policy, or buyback authorization for the period. Readers looking for a stated use of cash (debt paydown, M&A, capex, or shareholder returns) will need to look beyond this filing's narrative text; this section does not infer one. Peer or industry benchmarking of these cash-flow and balance-sheet lines is also absent from the filing evidence: The filing evidence contains no peer or industry comparison..

For readers weighing the headline lines in isolation, the practical picture is straightforward: operating cash generation strengthened year over year, the financing leg stayed positive and grew, the investing leg stayed negative but moderated, and the period-end balance sheet still carries a long-term debt stack alongside a meaningful cash position and a working-capital footprint in receivables and payables. A broader working-capital turn or net-debt computation is not attempted here, because the catalog does not expose the components needed to compute one. Anyone modeling liquidity runway can sanity-check assumptions with the ROI Calculator, but any number plugged into such a model should come from the audited filing rather than from this section.

Peer and historical context

Reported facts

- Revenue from Contract with Customer, Excluding Assessed Tax was $498,230,000 USD for the three months ended June 30, 2025, and was $622,720,000 USD for the three months ended June 30, 2026; the reported year-over-year direction for the quarter is an increase. - Revenue from Contract with Customer, Excluding Assessed Tax was $969,629,000 USD for the six months ended June 30, 2025, and was $1,198,351,000 USD for the six months ended June 30, 2026; the reported year-over-year direction for the six-month year-to-date period is an increase. - Operating Income (Loss) was $30,879,000 USD for the three months ended June 30, 2025, and was $39,468,000 USD for the three months ended June 30, 2026; both periods are profitable, the authorized direction is an increase, and the authorized transition is profit to profit. - Operating Income (Loss) was $6,778,000 USD for the six months ended June 30, 2025, and was $15,565,000 USD for the six months ended June 30, 2026; both periods are profitable, the authorized direction is an increase, and the authorized transition is profit to profit. - Net Income (Loss) Attributable to Parent was $14,454,000 USD for the three months ended June 30, 2025, and was $7,530,000 USD for the three months ended June 30, 2026; both periods are profitable, the authorized direction is a decrease, and the authorized transition is profit to profit. - Net Income (Loss) Attributable to Parent was -$23,472,000 USD for the six months ended June 30, 2025, and was -$25,936,000 USD for the six months ended June 30, 2026; both periods are losses, the authorized direction is a decrease, and the authorized transition is loss to loss. - Net Cash Provided by (Used in) Operating Activities was $161,829,000 USD for the six months ended June 30, 2025, and was $173,071,000 USD for the six months ended June 30, 2026; both periods are positive, and the authorized year-over-year direction for the six-month year-to-date period is an increase.

- The top-of-stack and the operating-line both moved in the same authorized direction across the quarter and the six-month window, which is internally consistent with continued growth in imaging service volume. Readers comparing RadNet's six-month revenue and operating-income trajectory against other mid-cap diagnostic-services filings such as Covista Inc. Reports Higher Revenue, Operating Income, Net Income, and Diluted EPS Across the Twelve-Month Period Versus the Prior-Year Comparative, With Each Line Remaining Profitable Year Over Year can see the same higher-revenue and higher-operating-profit pattern on the top of the P&L, although Covista's commentary covers a twelve-month window rather than a six-month year-to-date comparison. - The divergence between the operating-line direction and the bottom-line direction is the single most striking read: operating income is up year-over-year on both windows while net income attributable to parent moves down on both windows, and the half-year net result stays in a loss. The filing evidence does not attribute this change to any single cause. - Operating cash flow strengthening into the second quarter of the year, on top of higher revenue and higher operating income, suggests that the conversion of imaging-service activity into cash collections held up on a year-over-year basis even as the bottom-line result softened.

- The quarter net-income print is lower than the prior-year quarter, so a reader who looks only at the bottom line would see weakness even though revenue and operating income are both higher. The two readings of the filing are not contradictory, but they require a reader to separate the operating line from the parent net-income line before forming a view. - The six-month net-income line is a loss in both the current and prior periods, and the authorized direction is a deeper loss, so the year-to-date story at the parent level has not turned. Any framing of RadNet's half-year performance as a clean turnaround is therefore not supported by the authorized comparisons in the catalog. - The filing evidence contains no peer or industry comparison. - The filing evidence does not disclose segment-level detail for this dimension.

Scenario analysis

This section frames three conditional readings of what RadNet, Inc.'s 10-Q filing for period-ended-2026-06-30 (accession 0001628280-26-055338) implies under different operating outcomes, using only what the cited note and the consolidated statements disclose.

The base reading treats the reported windows as the midpoint. Revenue from Contract with Customer, Excluding Assessed Tax for the three-month reporting period of the three months ended June 30, 2026 came in at $622,720,000 USD, and for the six-month year-to-date period the six months ended June 30, 2026 it was $1,198,351,000 USD. Both readings sit above their prior-year comparatives of $498,230,000 USD (period the three months ended June 30, 2025) and $969,629,000 USD (period the six months ended June 30, 2025), consistent with the authorized directional view of year-over-year growth across the consolidated top line. The filing evidence does not attribute this change to any single cause. At the bottom line, the three-month period the three months ended June 30, 2026 closed with a positive Net Income (Loss) Attributable to Parent of $7,530,000 USD against $14,454,000 USD for the three months ended June 30, 2025, while the year-to-date period the six months ended June 30, 2026 reported a loss of -$25,936,000 USD versus a smaller loss of -$23,472,000 USD for the six months ended June 30, 2025.

The upside scenario reads the filing as evidence that quarterly profitability can extend into the second half. A positive three-month Net Income (Loss) Attributable to Parent of $7,530,000 USD for the three months ended June 30, 2026 alongside higher consolidated revenue versus the three months ended June 30, 2025 supports the view that quarter-level margins are intact, even while the year-to-date result remains a loss. Under this conditional reading, the cited segment disclosure Note 5 and the balance-sheet framing in Item 1 leave room for further revenue expansion without altering the cash-conversion mechanics referenced in Note 6 (Credit Facilities, Notes Payable, and Finance Lease) and the receivables treatment described in Note 7.

The downside scenario flags the year-to-date loss rather than the quarterly profit. Net Income (Loss) Attributable to Parent for the six months ended June 30, 2026 was -$25,936,000 USD against a smaller comparative loss of -$23,472,000 USD for the six months ended June 30, 2025, so the half-year result remains negative and widened relative to the prior year. The filing evidence does not attribute this change to any single cause. Because the filing does not disclose segment-level detail for this dimension, The filing evidence does not disclose segment-level detail for this dimension. the deterioration cannot be allocated to a specific reporting unit, and The filing evidence contains no peer or industry comparison. there is no peer or industry comparison to calibrate it against.

Readers weighing these scenarios can pressure-test the return framing with the ROI Calculator, since the base, upside, and downside readings depend entirely on how the reported revenue and net income figures for the periods above translate into cash-on-cash outcomes.

Risks and what to watch

- The most fragile part of the headline story is the gap between the quarter and the year-to-date window. Revenue from Contract with Customer, Excluding Assessed Tax is positive on a quarter-over-quarter basis for the three-month reporting period and positive on a half-year-over-half-year basis for the six-month year-to-date period, but the bottom line tells a different story. Net Income (Loss) Attributable to Parent shows a decrease year over year on both reported windows: the current quarter is still a profit versus the prior-year quarter, while the current half-year has slipped back into a loss versus a loss in the prior-year half-year.

The widening half-year loss alongside continuing top-line growth is the key tension in this filing and the metric to keep closest track of next period. - Management's own commentary, drawn from the cited notes, flags a different set of risks that the income statement alone does not surface. Note 7 explains that equity-based compensation is fair-valued through Black-Scholes or a binomial lattice model, which means the reported expense is exposed to assumptions about the risk-free rate and the volatility of the common stock; a sharp move in either input can swing compensation cost without any operational change.

The same note also notes that the vast majority of accounts receivable are due from third-party payors under fee-for-service contracts, including insurance companies and government-sponsored healthcare programs, and that the company maintains an allowance for bad debts based on identified payor collection issues and historical experience, so concentration in a small number of payors is a named exposure. Factoring arrangements are described as non-recourse and accounted for as a reduction in receivables, but the filing still ties proceeds to operating cash flow and to prepayment lines, which means factoring volume will continue to influence reported operating cash even when underlying collections are flat.

- Note 6 adds a balance-sheet overlay that belongs in any risk read: deferred financing costs are amortized through the effective-interest method against revolving credit facilities, so any change in facility size, covenant pressure, or refinancing terms will flow through interest expense without showing up as a revenue or volume item. Together with the equipment useful-life range that management cites for property and equipment, this means future-period margin direction will be shaped by financing structure and depreciation policy as much as by imaging volume.

- Counter-evidence worth weighing: operating income, on the authorized relations provided, increased year over year on both the three-month and six-month windows, staying profitable in both periods. That partially offsets the half-year net loss and suggests the deterioration is below the operating line rather than spread evenly across the income statement. Readers comparing this period against peers should note that the filing itself contains no peer or industry benchmark, so any external comparison must come from outside evidence; a side-by-side check against filings such as the Covista twelve-month report can be done through [Covista Inc.

Reports Higher Revenue, Operating Income, Net Income, and Diluted EPS Across the Twelve-Month Period Versus the Prior-Year Comparative, With Each Line Remaining Profitable Year Over Year](/insights/finance/covista-inc-reports-higher-revenue-operating-income-net-income-and-diluted-eps/), but no direct industry read is supplied here. - Unknowns to flag plainly: the filing evidence does not disclose segment-level detail for this dimension, so any read of which imaging line drove the gap is not supported here. The filing evidence does not disclose segment-level detail for this dimension.

The filing evidence does not attribute this change to any single cause. The filing evidence contains no peer or industry comparison. - Metrics to watch next period: the trajectory of Net Income (Loss) Attributable to Parent on the year-to-date basis, whether the quarter-over-quarter profit can be sustained, the direction of stock-based compensation expense as a share of operating cost, the aging and allowance posture on accounts receivable given payor concentration, and any change in the size or terms of the revolving credit facilities referenced in the cited note.